Lunaverse: The Future of Vaccine Access in Africa
Our Approach
Local Manufacturing Hub
We are developing a state-of-the-art vaccine production infrastructure in Nigeria to increase access, reduce import reliance, and ensure future supply security across Africa. Our facility focuses on mRNA, self-amplifying RNA (saRNA), protein subunit, viral vector, and DNA-based platforms, positioning LunaVax to meet regional needs with speed and innovation.
By investing in local production, we aim to strengthen self-reliance, reduce costs, and improve response times during outbreaks. We are also building strategic partnerships to co-develop vaccines aligned with Nigeria’s immunization priorities and the broader health needs of the continent.
Tech-Enabled Immunization Vans & Clinics
To expand immunization coverage, LunaVax deploys tech-enabled vaccination vans, mobile clinics, and pop-up immunization units across underserved communities in Nigeria and beyond. These units bring vaccines directly to people in remote and rural areas, reducing barriers like distance, infrastructure gaps, and limited healthcare access.
Integrated with our drone-powered delivery system, these smart vans enable on-the-spot immunization and outreach especially for children and adolescents ensuring fast, effective, and equitable vaccine delivery.
Drone Delivery & Smart Logistics
LunaVax is transforming last-mile immunization through drone-powered delivery and smart logistics. Our system overcomes poor infrastructure by reaching remote communities with autonomous flight paths and temperature-stable vaccines.
This reduces delivery time and eliminates cold chain barriers, ensuring timely access to life-saving immunizations in hard-to-reach areas. We support the drone-enabled delivery of select vaccines for Nigeria’s 11 high-priority diseases including measles, hepatitis B, yellow fever, DTP, and more, with ongoing innovation expanding access for HPV, TB, malaria, and others.
Microneedle Patches
LunaVax is pioneering needle-free immunization using microneedle vaccine patches, a painless, self-applicable solutions ideal for remote and underserved communities. These patches require no cold storage or trained personnel, making them well-suited for our drone and mobile clinic delivery systems.
Our current focus is on patch based delivery for measles, with ongoing research into expanding this model for HPV, TB, and malaria. These are diseases that continue to limit immunization coverage in Nigeria. This approach helps us reach more people, more efficiently, with less infrastructure.
Biometric Integration for Vaccine Access
To improve patient tracking, data accuracy, and continuity of care, LunaVax is introducing biometric technologies like fingerprint recognition and digital identity verification into our vaccine delivery programs.
These tools help identify individuals without formal IDs, prevent missed doses, and ensure every patient receives complete immunization. This innovation is especially impactful in regions where digital health records are limited, enabling equitable and data-driven vaccine access.
Every child deserves a shot at life. By fusing local production, last-mile delivery, and tech-driven care, LunaVax is proving what’s possible when we dare to be Lunacious.